[{"Assets_0_Q2_USD":2768694000.0,"EarningsPerShareBasic_1_Q2_USD":-0.03,"EarningsPerShareBasic_2_Q2_USD":-0.09,"EarningsPerShareDiluted_1_Q2_USD":-0.04,"EarningsPerShareDiluted_2_Q2_USD":-0.1,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-56583000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":564163808.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":563617274.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":559347540.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":558892375.0,"Ticker":"OPK","CIK":"944809","name":"OPKO HEALTH, INC.","OfficialName":"OPKO Health Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2187471532.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20170808"}]